Pulmonary Arterial Hypertension (PAH) Is Associated with Increased Non-Relapse Mortality after Allogeneic Hematopoietic Cell Transplantation (allo HCT) for Myelofibrosis

被引：0
|
作者：
Gupta, Rohan [1 ]
Jamal, Faizi [1 ]
Yang, Dongyun [2 ]
Ali, Haris [3 ]
Aldoss, Ibrahim [3 ]
Al Malki, Monzr M. [3 ]
Mei, Matthew [3 ]
Salhotra, Amandeep [1 ,3 ]
Dobrin, Surime [1 ]
Tran, Michael [1 ]
Venkataraman, K. [1 ]
Palmer, Joycelynne [2 ]
Stein, Anthony S. [3 ]
Sandhu, Karamjeet S. [3 ]
Khaled, Samer K. [3 ]
Aribi, Ahmed [3 ]
Marcucci, Guido [3 ]
Forman, Stephen J. [3 ]
Snyder, David S. [3 ]
Nakamura, Ryotaro [3 ]
Pullarkat, Vinod [3 ]
机构：
[1] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA
[2] City Hope Natl Med Ctr, Informat Sci, 1500 E Duarte Rd, Duarte, CA 91010 USA
[3] City Hope Natl Med Ctr, Hematol Hematopoiet Cell Transplant, 1500 E Duarte Rd, Duarte, CA 91010 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2019年 / 25卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
161
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Severe weight loss in 3 months after allogeneic hematopoietic SCT was associated with an increased risk of subsequent non-relapse mortality
    Fuji, S.
    Mori, T.
    Khattry, N.
    Cheng, J.
    Do, Y. R.
    Yakushijin, K.
    Kohashi, S.
    Fukuda, T.
    Kim, S-W
    BONE MARROW TRANSPLANTATION, 2015, 50 (01) : 100 - 105
  • [32] PRE-TRANSPLANT PULMONARY FUNCTION AND DAY 100 NON-RELAPSE MORTALITY AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Basa, S. K.
    Liesveld, J. L.
    Trawick, D. R.
    Fernandez, D.
    Nichols, D.
    Fisher, S. G.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 54 - 54
  • [33] Development and Validation of a Concise Objectifiable Risk Evaluation Score for Non-Relapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation
    Weise, Gunnar
    Massoud, Radwan
    Krause, Rolf
    Heidenreich, Silke
    Janson, Dietlinde
    Klyuchnikov, Evgeny
    Wolschke, Christine
    Zeck, Gaby
    Kroeger, Nicolaus
    Ayuk, Francis
    CANCERS, 2024, 16 (03)
  • [34] Etiology and Spectrum of Non-Relapse Mortality after Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation in Adults with Myeloid Neoplasms
    Eiten, Emily C.
    Hashmi, Shahrukh
    Litzow, Mark R.
    Hogan, William
    Gastineau, Dennis A.
    Patriaik, Mrinal
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S355 - S355
  • [35] Citrulline Trajectory during Allogeneic Hematopoietic Stem Cell Transplantation Is Correlated to Conditioning Intensity and Non-Relapse Mortality
    Gomes, Christopher Nunes
    Seegers, Valerie
    Schmidt, Aline
    Orvain, Corentin
    Villate, Alban
    Bouvier, Anne
    Simard, Gille
    Del Galy, Aurelien Sutra
    Francois, Sylvie
    Giltat, Aurelien
    Robin, Jean Baptiste
    Delneste, Yves
    Ifrah, Norbert
    Hunault, Mathilde
    Thepot, Sylvain
    BLOOD, 2020, 136
  • [36] Treatment of myelodysplastic syndromes with allogeneic hematopoietic stem cell transplantation (HSCT)-impact of non-relapse mortality on outcomes
    Ativitavas, T
    Saliba, R
    Sergio, G
    Ghosh, S
    Champlin, R
    de Lima, M
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 28 - 29
  • [37] Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell transplantation in non-remission acute leukemia
    Kurosawa, S.
    Yakushijin, K.
    Yamaguchi, T.
    Atsuta, Y.
    Nagamura-Inoue, T.
    Akiyama, H.
    Taniguchi, S.
    Miyamura, K.
    Takahashi, S.
    Eto, T.
    Ogawa, H.
    Kurokawa, M.
    Tanaka, J.
    Kawa, K.
    Kato, K.
    Suzuki, R.
    Morishima, Y.
    Sakamaki, H.
    Fukuda, T.
    BONE MARROW TRANSPLANTATION, 2013, 48 (09) : 1198 - 1204
  • [38] Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell transplantation in non-remission acute leukemia
    S Kurosawa
    K Yakushijin
    T Yamaguchi
    Y Atsuta
    T Nagamura-Inoue
    H Akiyama
    S Taniguchi
    K Miyamura
    S Takahashi
    T Eto
    H Ogawa
    M Kurokawa
    J Tanaka
    K Kawa
    K Kato
    R Suzuki
    Y Morishima
    H Sakamaki
    T Fukuda
    Bone Marrow Transplantation, 2013, 48 : 1198 - 1204
  • [39] Early Fluid Overload is a Serious Toxicity Associated with an Increased Risk of Non-Relapse Mortality after Ex-Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation
    Rondon-Clavo, Carlos
    Scordo, Michael
    Hilden, Patrick
    Shah, Gunjan L.
    Cho, Christina
    Maloy, Molly
    Papadopoulos, Esperanza B.
    Jakubowski, Ann A.
    O'Reilly, Richard J.
    Gyurkocza, Boglarka
    Castro-Malaspina, Hugo
    Tamari, Roni
    Shaffer, Brian C.
    Perales, Miguel-Angel
    Jaimes, Edgar A.
    Giralt, Sergio A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S314 - S316
  • [40] Comparable Survival with Organ Toxicity Predicting for Overall Survival (OS) and Non-Relapse Mortality (NRM) in Older Adult Patients after CD34+Selected Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HCT)
    Shah, Gunjan L.
    Scordo, Michael
    Kosuri, Satyajit
    Herrera, Diego A. Adrianzen
    Cho, Christina
    Maloy, Molly
    Nieves, Jimmy
    Devlin, Sean M.
    Borrill, Taylor
    Carlow, Dean
    Avecilla, Scott T.
    Meagher, Richard
    O'Reilly, Richard J.
    Koehne, Guenther
    Shaffer, Brian
    Perales, Miguel-Angel
    Gyurkocza, Boglarka
    Castro-Malaspina, Hugo
    Giralt, Sergio A.
    Tamari, Roni
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S83 - S84
12345